Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Functional inactivation but not structural mutation of p53 causes liver cancer.

Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G.

Nat Genet. 1995 Jan;9(1):41-7.

PMID:
7704023
3.

Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.

Henkler F, Waseem N, Golding MH, Alison MR, Koshy R.

Cancer Res. 1995 Dec 15;55(24):6084-91.

4.
5.
6.

[Hepatitis B X antigen binding to p53 protein in the pathogenesis of primary hepatocellular carcinoma].

Zhu MH.

Zhonghua Yi Xue Za Zhi. 1993 Jun;73(6):325-8, 379. Chinese.

PMID:
8258098
7.
8.

Molecular mechanism of hepatocarcinogenesis.

Sheu JC.

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S309-13. Review.

PMID:
9407351
9.

[Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma].

Zhu Z, Zhu M, Ni C.

Zhonghua Yi Xue Za Zhi. 2002 Oct 10;82(19):1332-6. Chinese.

PMID:
12509938
10.
12.

P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.

Katiyar S, Dash BC, Thakur V, Guptan RC, Sarin SK, Das BC.

Cancer. 2000 Apr 1;88(7):1565-73.

PMID:
10738214
14.

p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.

Volkmann M, Hofmann WJ, Müller M, Räth U, Otto G, Zentgraf H, Galle PR.

Oncogene. 1994 Jan;9(1):195-204.

PMID:
8302580
15.

Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.

Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC.

Oncogene. 2001 Jun 21;20(28):3620-8.

16.

Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.

Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H.

J Med Virol. 2000 Oct;62(2):151-8.

PMID:
11002243
17.

Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.

Lin Y, Shi CY, Li B, Soo BH, Mohammed-Ali S, Wee A, Oon CJ, Mack PO, Chan SH.

Ann Acad Med Singapore. 1996 Jan;25(1):22-30. Review.

PMID:
8779541
18.

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.

Hussain SP, Schwank J, Staib F, Wang XW, Harris CC.

Oncogene. 2007 Apr 2;26(15):2166-76. Review.

PMID:
17401425
19.

Genetic changes and histopathological grades in human hepatocellular carcinomas.

Konishi M, Kikuchi-Yanoshita R, Tanaka K, Sato C, Tsuruta K, Maeda Y, Koike M, Tanaka S, Nakamura Y, Hattori N, et al.

Jpn J Cancer Res. 1993 Aug;84(8):893-9.

PMID:
8407553
20.

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC.

Carcinogenesis. 1993 May;14(5):987-92.

PMID:
8389256
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk